Clinical trial
Transplantation of Hematopoietic Cells in Children With Severe Combined…
NCT00152100 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00152100 |
|---|---|
| Title | Transplantation of Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome |
| Official title | Transplantation of Highly Purified Haploidentical CD133 Hematopoietic Cells in Children With Severe Combined Immunodeficiency Syndrome |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Severe Combined Immunodeficiency |
| Intervention type | Device, Drug, Procedure |
| Interventions | Stem cell transplant, Filgrastim, Alemtuzumab, Miltenyi CliniMACS |
| Enrollment | 4 |
| Start date | Feb 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 9, 2005 |
| Last update posted | May 20, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: